
Sign up to save your podcasts
Or


Today on the Medscape Medical Minute: Is the unchallenged abortion pill as good as the mifepristone-misoprostol combination; a trial of statin therapy for cardiovascular prevention in HIV was stopped early for efficacy; and some insurers are refusing to pay for guideline-recommended MRI screening for patients who are at high risk for breast cancer.
By MedscapeToday on the Medscape Medical Minute: Is the unchallenged abortion pill as good as the mifepristone-misoprostol combination; a trial of statin therapy for cardiovascular prevention in HIV was stopped early for efficacy; and some insurers are refusing to pay for guideline-recommended MRI screening for patients who are at high risk for breast cancer.